3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Febrile Neutropenia
5
Neoplasms
4
Hematologic Neoplasms
3
Neutropenia
2
Urinary Bladder Neoplasms
1
Sepsis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Other Infectious Diseases
1
Leukemia, Myeloid, Acute
1
Fever
1
Emergencies
1
Interventions
trametinib
1
ofatumumab
1
liposomal amphotericin B
1
dabrafenib
1
Surveys and Questionnaires
1
Ritonavir
1
Quality of Life
1
Povidone-Iodine
1
Metformin
1
Meropenem
1
Lenalidomide
1
Daptomycin
1
Cloxacillin
1
Ciprofloxacin
1
Cilastatin, Imipenem Drug Combination
1
Ceftazidime
1
Cefepime
1
Caspofungin
1
Anti-Bacterial Agents
1
Amoxicillin
1
Amikacin
1
Administration, Intravesical
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fever
×
Meropenem
×
Clear all
NCT02149329
2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4
Completed
276 enrolled